Associated Papers
Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.
Dulucq S et al.
Expert Opinion on Drug Metabolism & Toxicology, 2014
Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia.
Lu Y et al.
British Journal of Cancer, 2014
24434428 (PubMed )
Supplement: bjc20147x1.doc
Select a paper to view details